Literature DB >> 8423717

Effectiveness of the Short TI Inversion Recovery (STIR) sequence in MR imaging of intramedullary spinal lesions.

M Mascalchi1, G Dal Pozzo, C Bartolozzi.   

Abstract

A Short TI Inversion Recovery (STIR) sequence with spin-echo data collection was compared to a conventional cardiac gated long TR spin-echo (SE) sequence for detecting intramedullary signal abnormalities. The cervical (n = 48), cervico-thoracic (n = 1), and thoraco-lumbar (n = 18) spinal cord was imaged in a sagittal plane with a 0.5 T (n = 61) or 1.5 T (n = 6) MRI unit in 67 patients with clinical evidence of myelopathy of different etiologies (e.g., multiple sclerosis, trauma, herniated intervertebral disk, spondylosis, etc.). In all patients, ungated double or quadruple echo STIR images (TR 1000-1400 msec, TI 100 msec, TE 30-60 or 30-60-90-120 msec) were compared with cardiac gated long TR (1400-2100 msec), double echo (30-100, 50-100, or 50-150 msec) SE images with first order flow compensation for the second echo. Although STIR images appeared "noisier" than long TR SE images, they showed fewer ghost artifacts. In 55 patients, single or multiple, focal or diffuse, hyperintense areas within the spinal cord were observed on both long TR SE and (magnitude reconstructed) STIR images. Lesion conspicuity was better on the STIR images in 25 patients, better on the SE images in 14 patients, and equal in 16. STIR sequence provides a valuable alternative to gated long TR SE sequence for the MRI investigation of intramedullary spinal lesions.

Entities:  

Mesh:

Year:  1993        PMID: 8423717     DOI: 10.1016/0730-725x(93)90407-5

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  7 in total

1.  Evaluation of lumber nerve root compression using thin-slice thickness coronal magnetic resonance imaging: three-dimensional fat-suppressed multi-shot balanced non-steady-state free precession versus three-dimensional T1-weighted spoiled gradient-recalled echo.

Authors:  Keizo Tanitame; Nobuko Tanitame; Chihiro Tani; Masaki Ishikawa; Miyuki Takasu; Shuji Date; Keiko Otani; Kazuo Awai
Journal:  Jpn J Radiol       Date:  2011-09-29       Impact factor: 2.374

Review 2.  Magnetic resonance imaging of intramedullary spinal cord tumors.

Authors:  G M Lowe
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

3.  Imaging diagnosis of lumbar foraminal stenosis in the fifth lumbar nerve root: reliability and reproducibility of T1-weighted three-dimensional lumbar MRI.

Authors:  Ko Hashimoto; Yasuhisa Tanaka; Takumi Tsubakino; Takeshi Hoshikawa; Tomowaki Nakagawa; Takashi Inawashiro; Kohei Takahashi; Masaru Suda; Toshimi Aizawa
Journal:  J Spine Surg       Date:  2021-12

4.  Comparison of Sagittal FSE T2, STIR, and T1-Weighted Phase-Sensitive Inversion Recovery in the Detection of Spinal Cord Lesions in MS at 3T.

Authors:  P Alcaide-Leon; A Pauranik; L Alshafai; S Rawal; J Oh; W Montanera; G Leung; A Bharatha
Journal:  AJNR Am J Neuroradiol       Date:  2016-01-21       Impact factor: 3.825

5.  Optimized T1-MPRAGE sequence for better visualization of spinal cord multiple sclerosis lesions at 3T.

Authors:  G Nair; M Absinta; D S Reich
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-13       Impact factor: 3.825

6.  Midsagittal tissue bridges are associated with walking ability in incomplete spinal cord injury: A magnetic resonance imaging case series.

Authors:  Denise R O'Dell; Kenneth A Weber; Jeffrey C Berliner; James M Elliott; Jordan R Connor; David P Cummins; Katherine A Heller; Joshua S Hubert; Megan J Kates; Katarina R Mendoza; Andrew C Smith
Journal:  J Spinal Cord Med       Date:  2018-10-22       Impact factor: 1.985

Review 7.  Spinal vascular lesions: anatomy, imaging techniques and treatment.

Authors:  Valerio Da Ros; Eliseo Picchi; Valentina Ferrazzoli; Tommaso Schirinzi; Federico Sabuzi; Piergiorgio Grillo; Massimo Muto; Francesco Garaci; Mario Muto; Francesca Di Giuliano
Journal:  Eur J Radiol Open       Date:  2021-07-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.